Dossier assessment

Mirikizumab (ulcerative colitis) - Benefit assessment according to § 35a Social Code Book V

Status
Status: Commission completed
Project no.
A23-73
Last updated

Report documents

  1. Extract of dossier assessment

    Mirikizumab (ulcerative colitis) - Benefit assessment according to § 35a Social Code Book V

    published on
    Document type
    PDF document, 354 kB, EN, not accessible
  2. Dossier assessment

    Mirikizumab (ulcerative colitis) - Benefit assessment according to § 35a Social Code Book V

    published on
    Document type
    PDF document, 610 kB, DE, not accessible
    DOI-Link
    https://doi.org/10.60584/A23-73

Dossier assessment

Indication:

Adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment

Result of dossier assessment:
  • Patients who have had an inadequate response with, lost response to, or are intolerant to conventional therapy: added benefit not proven
  • Patients who have had an inadequate response with, lost response to, or are intolerant to biologic treatment: added benefit not proven

Project details

Project no.
A23-73
Commission
Commission awarded on 14.07.2023 by the Federal Joint Committee (GBA).
Report type
Dossier assessment
Status
Commission completed
Department/Division
Drug Assessment
Topic
Digestion, metabolism and hormones
Note

After completion of the assessment by IQWiG the Federal Joint Committee (GBA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the GBA website.

DOI

https://dx.doi.org/10.60584/A23-73

Connected Projects

  1. Dossier assessment

    Mirikizumab (Crohn’s disease) – Benefit assessment according to §35a Social Code Book V

    Project no.
    A25-42
    Last updated

    Status: Commission completed

Contact

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form